The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network
Abstract
Introduction: Cephalosporins are widely prescribed antibiotics due to their efficacy and safety. Although rare, idiosyncratic drug‐induced liver injury (DILI) has been reported with their use. Here, we characterise the clinical features and HLA associations of cephalosporin‐related liver injury. Methods: Between Jan 1, 2004, and Nov 2, 2022, a total of 2347 cases of DILI were enrolled in the DILIN study, of which 1854 were adjudicated as probable, highly likely, or definite. HLA sequencing was performed, and association with the risk of DILI was examined. Results: 58 cases (3%) were attributed to different cephalosporins, including cefazolin ( n = 40), cephalexin ( n = 4), ceftriaxone ( n = 3), cefdinir ( n = 3), cefuroxime ( n = 3), and five other individual agents. Clinical features included a self‐limited course with a mixed or cholestatic biochemical pattern without hypersensitivity features occuring in 1 to 4 weeks. Most striking was the phenotype of cefazolin and other parenteral cephalosporins given as a single dose with the onset of jaundice, fatigue, and itching 1 to 3 weeks later. In the total cohort, HLA‐A*02:01 was significantly associated with an increased risk of cephalosporin‐induced liver injury (OR: ~2.5–2.7, P < 0.0001). The association was strongest with cefazolin, with carrier frequencies of 85% vs. 38% in those with DILI from other drugs. Conclusions: Cephalosporins can cause self‐limited, mixed/cholestatic hepatitis that arises after a short course of therapy with a latency of up to 3 weeks with cefazolin. Cephalosporin‐induced liver injury is associated with the HLA‐A*02:01 allele, which is linked to more severe liver injury at the onset of illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HLA polymorphisms shown to be significantly associated with multiple drugs include HLA-A*02:01 for AC and cefazolin DILI and HLA-B*35:01 for multiple HDS products, including green tea extract, turmeric, and Polygonum multiform.”
From The contemporary epidemiology, causes, and management of drug-induced liver injury (2026) · cites this paper as [30]
In the citing paper
“Several polymorphisms in human leukocyte antigen (HLA) class I and II alleles have been associated with drug-specific idiosyncratic DILI (Table 3).29–37”
From The contemporary epidemiology, causes, and management of drug-induced liver injury (2026) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
The positive false discovery rate: a Bayesian interpretation and the q-value
Storey, J. D. (2003) · The Annals of Statistics · doi:10.1214/aos/1074290335 · Cited by 2,204
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., International SAE Consortium, Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe'er, I., Floratos, A., Daly, M. J., Goldstein, D. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 944
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Self-citationANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Chalasani, N., Fontana, R. J., Bonkovsky, H. L., Watkins, P. B., Davern, T., Serrano, J., Yang, H., & Rochon, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.011 · Cited by 755
Self-citationDrug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Self-citationThe Use of Cephalosporins in Penicillin-allergic Patients: A Literature Review
Campagna, J. D., Bond, M. C., Schabelman, E., & Hayes, B. D. (2012) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2011.05.035 · Cited by 243
Cephalosporins as key lead generation beta-lactam antibiotics
Lin, X., & Kück, U. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12272-8 · Cited by 148
Research works printed but not linked: 3
- Bui T., 2024, StatPearls
- 2012, LiverTox: Clinical and Research Information on Drug‐Induced Liver Injury
- Gilani B., 2024, HLA B 5701 Testing
Cited by
The contemporary epidemiology, causes, and management of drug-induced liver injury
Swanson, L., & Fontana, R. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001011
Self-citation
Metadata
- Authors
- Vuppalanchi, R., Li, Y., Rockey, D. C., Halegoua‐DeMarzio, D., Fontana, R. J., Bonkovsky, H. L., Koh, C., Odin, J., Barnhart, H., Hoofnagle, J. H., & Drug‐Induced Liver Injury Network (DILIN)
- Affiliations
- Indiana University School of Medicine Indianapolis Indiana USA
- Duke University School of Medicine Durham North Carolina USA
- Medical University of South Carolina Charleston South Carolina USA
- Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia Pennsylvania USA
- University of Michigan Ann Arbor Michigan USA
- Atrium Health Wake Forest Baptist and Wake Forest University School of Medicine Winston‐Salem North Carolina USA
- National Institute of Diabetes and Digestive and Kidney Diseases Bethesda Maryland USA
- Icahn School of Medicine at Mount Sinai New York New York USA
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2025-07-20
- Volume
- 62
- Issue
- 10
- Pages
- 1012-1022
- ISSN
- 0269-2813
- 1365-2036
- PMC
- PMC12543336
- Cited by
- 10
- References
- 29
- Language
- en
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK065211, U01DK065184, U01DK065201, U01DK083020, U01DK083027, U24DK065176)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network. https://app.cochat.ai/papers/10.1111/apt.70284
- The paper
- Vuppalanchi, R., Li, Y., Rockey, D. C., Halegoua‐DeMarzio, D., Fontana, R. J., Bonkovsky, H. L., Koh, C., Odin, J., Barnhart, H., Hoofnagle, J. H., & Drug‐Induced Liver Injury Network (DILIN). (2025). Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.